Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
KIT D816V Mutation clinical trials
1 of 2 indexed KIT D816V Mutation trials are currently recruiting.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count
KIT D816V Mutation: 2 US clinical trials tracked, 1 recruiting.
KIT D816V Mutation is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Blueprint Medicines Corporation, running 2 of these trials.
Enrollment posture brief
Registry condition kit-d816v-mutation
OPEN 1 | RECR 50% | LATE 0 | EARLY 0 | RANK #7188 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
KIT D816V Mutation lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for KIT D816V Mutation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
KIT D816V Mutation is recruiting above its size-band peers.
1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Blueprint Medicines Corporation
NCT07143669
(PROSPECTOR) Screening Study Evaluating the Prevalence of the KIT D816V Mutation in Patients With Systemic Mast Cell Activation
Blueprint Medicines Corporation
NCT04811365
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on KIT D816V Mutation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on KIT D816V Mutation trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this KIT D816V Mutation page
2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 KIT D816V Mutation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Blueprint Medicines Corporation sponsors the most KIT D816V Mutation trials on record, review their full trial history before evaluating a specific study. See Blueprint Medicines Corporation's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This KIT D816V Mutation condition card totals 2 registered trials; most-linked intervention Screening; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.